The following table provides an overview of the latest patents of Purdue Research Foundation that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3866765Feb 7, 2024Injectable Long-Acting Naltrexone Microparticle Compositions1
EP2981180Dec 29, 2021Uses Of Soluble Corn Fiber For Increasing Colonic Bacteria Populations And Increasing Mineral Absorption1
EP2187965Oct 9, 2019Psma Binding Ligand-Linker Conjugates And Methods For Using2